Board of Medical Examiners and Medical Licensure Commission Newsletter and Report

  • The Board newsletter contains information impacting licensees and a list of disciplinary actions against licensees.
  • All current licensees receive the Board Newsletter and Report at the address of record at no charge.
  • Licensees may also choose to receive the newsletter by email.
  • Non-licensee subscriptions to the newsletter are by email only.
  • If you would like to receive the newsletter by email, please send a request to and include your name, address, city, state, zip code, telephone number and email address.

Receive alerts for new newsletters, public actions, agendas, etc.

Latest newsletter Cover of latest newsletter

Issue Vol. 34, Vol. 3, Jul. - Sept. 2019

Article topics include:

• 2020 license and registration renewals
• Notice - Licensee Portal
• Welcome to new employees
• ALBME social media guidelines
• Starting Nov. 18 Gabapentin will be a Schedule V drug
• Administrative rule changes
• Public actions of the Board and Commission

Newsletter Archives
Volume 34 (2019) Featured articles
No. 1 • New Executive and Associate Executive Directors
• Administrative rule changes
• Doctors positively impacting state's opioid crisis
• Notice to Limited License Holders
• What do you need to know about CME for controlled substances?
• 2018 Annual Report
• NarxCareTM comes to PDMP
• Public actions of the Board and Commission
No. 2 • ALBME welcomes new Board members for 2019-2020
• Effective Nov. 18:  Gabapentin changed to Schedule V
• Underwood Minority Scholarship Award announced
• Do you have patients who live or travel extensively outside the country?
• Be sure of accreditation status of ALS, PALS, ACLS providers
• Disaster planning for your medical practice
• DEA warns of alarming increase in scam calls
• Use of lasers and other modalities affecting living human tissue
• Public actions of the Board and Commission
No. 3 • 2020 license and registration renewals
• Notice - Licensee Portal
• Welcome to new employees
• ALBME social media guidelines
• Starting Nov. 18 Gabapentin will be a Schedule V drug
• Administrative rule changes
• Public actions of the Board and Commission
No. 4 January 2020
Volume 33 (2018) Featured articles
No. 1 • ALBME 2017 Annual Report
• Controlled subs. prescribing issues for mid-levels/physicians
• Reminder:  New CME requirement for ACSC holders
• Health professionals disaster response volunteer network
• Alabama physician workforce profile
• APHP announces reorganization
• Web site and online licensure update
• Public actions of the Board and Commission
No. 2 • BME/MLC welcome new members
• Naloxone available OTC
• In Memoriam: Ronnie Lee Lewis, MD
• Kenneth Aldridge, MD, receives Garber Galbraith Medical-Political Award
• BME staff update
• New:  Additional QACSC at lower fee
• CME opportunities
• Alabama Quitline
• Online application forms available this fall
• Public actions of the Board and Commission
No. 3 • 2019 license and registration renewals
• Notice to Limited and Retired Senior Volunteer License Holders
• Benzodiazepine use, misuse, and abuse
• Important reminder for collaborative practice physicians
• Changes to Office Based Surgery registration
• Attn:  lawful aliens/foreign national licensees
• Licensee Portal update
• FSMB: regulating use of stem cell and regenerative therapies
• IMLC now covers half the country
• Public actions of the Board and Commission
No. 4 • Board members recognized
• Recent physician survey responses highlight issues with EHRs
• Medical conditions/controlled substances and operating vehicles
• Clarence Neal "Buddy" Canup, MD, in memoriam
• Important information for mid-level practitioners
• Board rule changes
• Special registration for prescribing controlled substances via telemedicine
• Public actions of the Board and Commission
Volume 32 (2017) Featured articles
No. 1 • Questions about the new RMS rule
• How to register for the AL Electronic Death Registration System
• ALBME names new executive director
• Risk and abuse mitigation strategies for prescribing physicians
• 2016 ALBME annual report
• If you need help - Alabama Physician Health Program
• Public actions of the Board and Commission  
No. 2 • Rescheduling selected drugs
• Board welcomes new members Drs. Jordan, Lewis and Rogers
• Board says farewell to Drs. Goetter and Smith
• Social media and electronic communication with patients
• Notices and reminders
• CME requirement for ACSC registrants FAQs
• Public actions of the Board and Commission
No. 3 • Big changes to web site, online renewal applications
• 2018 license and registration renewals
• Notices to Limited/RSV/nonpermanent legally present licensees
• Changes coming to PDMP
• DEA releases 2017 Drugs of Abuse resource guide
• FDA to require expanded training on opioids
• Achieve successful transition to MACRA's QPP
• PAs/CRNPs/CNMs prescribing to self or immediate family
• CME notices
• Public actions of the Board and Commission
No. 4 • African-American female Dr. Halle Tanner Dillon
• Repairing "difficult" patient-clinician relationships
• Free refresher training for Certified Medical Examiners
• PDMP update
• How to make HIPAA disclosures during mass tragedies
• Interstate Medical Licensure Compact update
• CME in 2018
• Public actions of the Board and Commission
Volume 31 (2016) Featured articles
No. 1 • 2015 Annual Report
• Interstate Medical Licensure Compact
• Alabama's Electronic Death Registration System
• Meet Norris W. Green, Associate Executive Director
• How does the PDMP apply to me?
• Need CME?  Prescribing of Controlled Drugs and Opioid Prescribing
• Medical Association News
• Professionalism in the use of social media
• CME compliance
• Public actions of the Board and Commission  
No. 2 •  AIM Award for Development of Prescribing Courses
•  Medical Assoc. Honors BME Investigator Munson
•  Meet the New Board Members
•  BME Investigations: What Happens When There is a Complaint?
•  George Smith, Sr., MD, Receives National Award
•  Opioid Pain Medicines - FDA Warning
•  William F. Addison, Esq., Retires
•  Meet the Staff:  E. Wilson Hunter, Esq.
•  BME Mourns Loss of Staff Member Cindy Kirsch Smith
•  Public actions of the Board and Commission
No. 3 • Billing Fraud
• New Federal Buprenorphine Prescribing Rule
• 2017 License and Registration Renewals
• Notice to Limited License and Retired Senior Volunteer license holders
• CME Requirement for Physicians and Physician Assistants
• Important Reminder for Collaborative Practice Physicians
• Attention Lawful Aliens/Foreign National Licensees
• CDC Develops Useful Resources for Physicians and Patients
• Notice for Dispensing Physicians
• Famous Alabama Physician:  Peter Henderson Bryce, MD
No. 4 • A report on Interstate Medical Licensing Compact
• Important notice from DEA (change in renewal process)
• FDA warns of combining opioids and benzodiazepines
• Healthcare personnel should get influenza immunization
• HHS announces actions to combat opioid epidemic
• In memory of James "Nick" Nichols
• Public actions of the Board and Commission
• CME in 2017
Volume 30 (2015) Featured articles
No. 1 • Collaborative Practice Agreement renewal and termination
• Alabama BME Annual Report
• In memory of Arthur F. Toole, Jr., MD
• Differentiation between electronically transmitted and electronic medical record produced prescriptions
•  Public actions of the Board and Commission  
No. 2 •  Alabama joins Interstate Medical Licensure Compact
•  Patients, pain and physicians
•  Communication between physicians and patients
•  Internet drug sellers:  what providers need to know
•  Notice: Requesting medication approvals under LPSP
•  Public actions of the Board and Commission  
No. 3 •  Arrest, Search and Seizure in Mobile
•  2016 License and Registration Renewals
•  Notice to Limited License and RSVP License Holders
•  Professionalism in the Practice of Medicine (reprint)
•  Tribute to William Jefferson Terry, MD
•  PA Corner - FTE Increase, 2016 Renewals
•  Reminders - Dispensing, Lawful Alien Licenses, FDA -Testosterone
•  Public actions of the Board and Commission   
No. 4 •  Outside expert witnesses needed
•  The distressed physician:  Not 'bad doctor'
•  John Meigs, MD, FAAFP, elected president elect of the AAFP
•  Ann Streetman Shiver retires after 36 years
•  Notice regarding Contrave®
•  Update:  Board Rules Chapter 540-X-15, Telehealth
•  10 Big healthcare predictions for 2016
•  Public actions of the Board and Commission
Volume 29 (2014) Featured articles
No. 1 •  The pain medication dilemma
•  Medical examiners must be certified to conduct DOT physicals
•  Ending diversion of prescribed medicines
•  2013 Annual Report
•  Providing records of other physicians
•  Termination of collaborative practice/registration agreement
No. 2 •  Terminating a physician/patient relationship
•  Alert regarding hormone pellet placement
•  Dixon receives lifetime achievement award
•  November courses - medical ethics, prescribing of controlled drugs, ER/LA Opioid Analgesics REMS
No. 3 •  License renewal: proving US citizenship/lawful permanent resident status
•  2015 license/registration renewals
•  DEA final rule reschedules hydrocodone combination products
•  Physician impairment: what should I do?
•  Limited Purpose Schedule II Permit (LPSP)
No. 4 •  Limited Purpose Schedule II Permits for NPs and PAs
•  Alert regarding hormone pellet therapy
•  Q&A:  Disruptive behavior among physicians
•  Physician impairment: what should I do?
•  FDA approves new, hard to abuse hydrocodone pill
•  Third edition of "Responsible Opioid Prescribing" book
•  UAB School of Nursing Ebola course
•  PA Corner
Volume 28 (2013) Featured articles
No. 1 • Special 2013 Legislative Edition
• Immigration Act requires proof of citizenship/legal presence
• Drug Abuse and Diversion package becomes law
• Nurse Practitioner prescribing legislation passes 
No. 2 • Pain Medicine Legislation:  An overview
• Nurse practitioner prescribing update
• 2012 Annual Report
• Hyperbaric Oxygen Therapy uses and abuses
• Physician Health Program reporting requirements
• Report of public actions of Board and Commission
Volume 27 (2012) Featured articles
No. 1 •  Treating androgen deficiency in the aging male
•  BME 2011 Annual Report
•  DEA announcement - carisoprodol (Soma)
•  Dispensing physician registration
•  A call to preceptors
No. 2 • Testosterone replacement from endocrinologist's perspective
• CME rule amendment - grace period eliminated
• Providing records of other physicians
• PA controlled substances prescribing reminder
• Reminder - collaborative practice renewal and termination
No. 3 •  Board expresses concern regarding use of chelating agents
•  2013 license and registration renewals
•  BME/MASA educational programs offer valuable CME
•  Registrations with the Board (office-based surgery, lasers, dispensing)
•  Qualified Alabama Controlled Substances Certificate (P.A.s) requirements
•  DEA certification for electronic prescribing
•  Use of non-validated substances for weight reduction under scrutiny
•  Maintenance of licensure (MOL) update
No. 4 • Health Department survey/email address request
• Update on chelation therapy study
• Board to address prescription drug diversion
• Legibility of prescriptions, required info a concern to pharmacists
•  Medicaid announces enrollment requirements
•  Home assessments and home visits
•  Termination of collaborative practice/registration agreement
•  Avoid complaints to the Board
•  Special pull-out section - Board rules on prescribing/pain management
Volume 26 (2011) Featured articles
No. 1 • DEA rules for electronic prescribing of controlled substances
• ABME 2010 Annual Report
• MASA/ABME prescribing seminar
• AMA policy for use of social media
• Prescription Drug Monitoring Database
No. 2 • Best of Boards Award - Collaborative Practice Seminar
• AQAF membership for physicians
• PDMP database system upgraded
• PAs controlled substances prescribing protocol
• Activities misunderstood to confer Category 1 credit
• Providing records of other physicians
No. 3 • 2012 license and registration renewals
• Volunteering for health emergencies
• CME reminders
• ADPH invites physicians to volunteer through Alabama Responds
• Prescription drug monitoring program important reminders
No. 4 • Male infertility - a common side effect of testosterone therapy
• Registration for office based surgery
• DEA e-prescribing rules clarifications
• New Board Rule - utilizing controlled substances for weight reduction
• Report of public actions of Board and Commission
Volume 25 (2010) Featured articles
No. 1 • Board discourages use of HCG for treatment of obesity
• Office-based surgical procedures
• MASA/ABME prescribing seminar
• Rules governing the use of lasers
• Treating and prescribing to family members
No. 2 • Medical communication
• CME requirement change for 2010
• Maintenance of licensure
• Treating and prescribing to family members - a follow up
• FDA on lipodissolve, refilling pain pumps
No. 3 • Information for 2011 renewals
• Understanding CME:  what are Category 1 or equivalent credits?
• Exercise care in annual renewals
• Surveys determine benefit eligibility (ADPH)
No. 4 • Use of non FDA approved hormones
• Changes to Office Based Surgery Rules
• 2010 Annual Report
• DEA policy change - authorized agent
• FDA electronic tools
Volume 24 (2009) Featured articles
No. 1 • New collaborative practice rules by CMS
• Appropriate prescription formats
• MASA/ABME prescribing seminar
• Utilization of mid-level practitioners
• PDMP a useful tool
No. 2 • Using controlled substances for the treatment of pain
• A Board member's thoughts on obtaining CME
• Ala. Act expands PA prescribing
• PDMP zero based reporting
• FSMB honors MLC member, BME Executive Director
No. 3 • Information for 2010 renewals
• CME requirement to change for 2011 renewals
• Prescribing controlled substances by PAs
• FSMB news
No. 4 • The value of physician health programs
• Prescribing controlled drugs seminar
• Required information for prescription forms
• QACSC rules
• Potential indicators of drug abuse/fraud
Volume 23 (2008) Featured articles
No. 1 • Recommendations for weight loss programs
• Online communication with patients
• Rules about medical records
• Utilization of mid-level practitioners
• Signature requirements for prescriptions
No. 2 • Using the PDMP database
• Ambulance transport rules
• Laser rules compliance date approaching
• Retired senior volunteer program
• Internet prescribing legislation passes US Senate
No. 3 • Professional sexual misconduct
• Criminal background checks
• Treating and prescribing to family members
• ADPH publishes list of controlled substances
No. 4 •  Avoid complaints to the Board
•  Patient conditions reportable by physicians
•  What to expect in a collaborative practice audit
•  Joint Commission issues alert on disruptive behavior
•  Ryan Haight Online Pharmacy Consumer Protection Act
Volume 22 (2007) Featured articles
No. 1 • Advertising by physicians
• Prescription Drug Monitoring Program
• Board opinions - joint injections by mid-level practitioners
No. 2 • Avoid common prescription problems
• CMS rule requiring tamper-proof prescription pads
• Collaborative agreements/registration
• Procedures for PAs performing skin biopsies
No. 3 • Board adopts rules for using lasers
• Laser rules increase physician responsibilities
• Use of Methadone for chronic pain management
No. 4 • DEA rule change on frequency of prescribing controlled substances
• Anabolic steroids and performance enhancing drugs
• Weight loss clinics cause concern for the Board
• Resigning hospital privileges may have unintended consequences
• Over-the-counter insulin users may forego regular doctor visits
Volume 21 (2006) Featured articles
No. 1 • Using mid-level medical practitioners
• Prescription Drug Monitoring Program - Board Rules
• Professionalism in the practice of medicine
• Board encourages prevention (chemical dependency)
No. 2 • Laser use in clinical medicine
• Physician medical records
• Board revises PA joint procedures policy
• Board opinion - facial biopsies, arthocentesis, joint injection by mid-levels
• Board opinion - pain pumps and dispensing physicians
• Closing or retiring from a practice
No. 3 • What to expect if a representative of the Board visits your office
• Physician responsibilities when managing reports from screening agencies
• BME issues opinion on pain pump refills
• Internet prescribing
No. 4 • Store-based health clinics - guidelines to promote quality and safety
• Communication between physicians and patients
• Board opinions - ear stapling
• The sagging of medical professionalism

A .zip file of pre-2006 newsletters can be located here. (File is 1.39GB)

Copyright 2018 The Alabama Board of Medical Examiners
All rights reserved